APPENDIX 1 Food Drug Interphase FDI Products
APPENDIX 1 Food Drug Interphase FDI Products
APPENDIX 1 Food Drug Interphase FDI Products
APPENDIX 1
This guide serves to assist in determining if a product is regulated by the National Pharmaceutical
Regulatory Agency (NPRA) or by the Food Safety and Quality Division (FSQD) of the Ministry of
Health Malaysia.
1. INTRODUCTION
Malaysians are now more health conscious and there is generally greater awareness of the
importance of nutrition to overall well-being. In recent years, many consumers also rely on a
variety of “dietary supplements” to improve their health. These diverse products are freely
available through a myriad of outlets. A variety of products are available in the market, supposedly
for the maintenance, prevention and even treatment of chronic diseases. These products may range
from foods modified to have special properties or pure forms of vitamins and minerals to extracts
of various botanical or animal products.
It is important to monitor and regulate the marketing and sale of these products to protect the
interest and health of the consumer. Some of these products are not clearly defined as “food” or
“drugs” but are freely marketed. Such products include a variety of so-called health products and
have been termed as “food-drug interphase (FDI) products”.
In order to better define and regulate the FDI products, both the NPRA and the FSQD, Ministry of
Health Malaysia formed the Committee for the Classification of Food-Drug Interphase Products in
2000. The main Terms of Reference of the Committee is to assist both Divisions in classifying, in a
consistent manner, any application from the industry not clearly defined either as a food or drug
product. The Committee also serves as a platform in strengthening and updating the relevant
regulations as well as to provide scientific input on these products.
2.2 Food products with or without active ingredients (e.g.: herbs, vitamins, minerals,
etc.) such as:
i) Instant drink products containing sugar and creamer (e.g. premix coffee, tea,
chocolate, soy, cereal)
Page 1 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
ii) Meat essence products (liquid) (e.g. chicken essence, ostrich essence, duck
essence, fish essence, etc.)
iv) Cordial products with recommended dilution ratio (e.g. dates cordial, grape
cordial)
v) Vinegar products (powder & liquid) (e.g. apple vinegar, dates vinegar, etc.)
2.3 Isotonic drink products, sport nutrition products and special purpose food products
2.4 Products in conventional food form, e.g. biscuit, cake, confectionery, candy/sweet,
gummy, noodle
2.5 Products used for cooking and food preparation (e.g. cooking oil (olive oil, coconut
oil, sunflower oil), herbs and spices)
2.6 Herbs and spices in crude form without medicinal/ health claim
3.2 Products containing specific active ingredients, which possess high pharmacological
or therapeutic potencies. Examples of the ingredients are paracetamol,
glucosamine, tranexamic acid, aspirin, and substances listed in Poisons Act 1952
3.4 Products in pharmaceutical dosage form, such as soft gel, capsule or tablet (that is
to be directly swallowed), sublingual, buccal, spray into the mouth, etc.
Page 2 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
4. FDI PRODUCTS
Generally, FDI products are products with combination of food ingredients and active
ingredients for oral consumption. FDI products are not clearly defined as food or drug.
Examples of food ingredients are fruits, vegetables, meat, poultry, milk, cocoa and cereal.
Examples of active ingredients are vitamins, minerals, herbs, enzymes, probiotics,
prebiotics, amino acids, peptides, coral calcium, fatty acids, collagen, chia seed, astaxanthin,
lutein and other ingredients that are not traditionally consumed as food. FDI products may
be presented in the form of powder, liquid, semisolid forms such as gel/ jelly, chewable
tablet, drops, granule, etc.
a) Main criteria
i. Negative List for FDI as listed in Table I: Negative List For FDI:
FDI products containing ingredient(s) from Negative List for FDI shall be regulated
by NPRA; or
ii. Medicinal/ health claim refer to the term “medicinal purpose” as stipulated in
the Sales of Drug Act 1952, Section 2:
FDI products not containing ingredient(s) from Negative List for FDI and with
medicinal/ health claim shall be regulated by NPRA; or
FDI products not containing ingredient(s) from Negative List for FDI and without
medicinal/ health claim shall be regulated by FSQD.
b) Other criteria
When there is greater uncertainty regarding the safety of a FDI product, such product
shall be regulated by NPRA. This is to enable closer monitoring of such product to
safeguard the health of the consumer.
Page 3 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
Contact the relevant regulatory agencies for clarification, or seek classification service from
NPRA by submitting a classification application should there be doubt or uncertainty
pertaining to the category of the product.
Read the governing legislations and other regulatory requirements and guidelines that
apply to the product before using this guide.
NO
2. ** Medicinal/Health Claim
Is the product indicated for medicinal purpose, or
does the product label/packaging contain any YES Drug
2. Medicinal/
statement that indicates or implies any medicinal Health Claim
purpose (e.g. body weight control; for the health
benefit of eyes specific human organs/ systems, such
as gastro-intestine and/or brain)?
NO
Food
Note: ** NPRA reserves the right to use its discretion to make decision if any issue of subjectivity
arises.
Page 4 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
5. ADDITIONAL NOTES
5.1 Substances listed in the prohibited/ banned ingredient list of the Drug Registration
Guidance Document (DRGD) and Schedule Poison shall not be permitted for use in
any FDI products.
5.2 Products categorized as a natural product are not allowed to contain creamer.
5.3 Food products are not allowed to be packed in blister pack/ any other form of
packaging that resembles the packaging of drug product.
5.4 Any foods or combination of foods that are regulated by FSQD shall not be in
pharmaceutical dosage form. Such products are advised to be reformulated into a
non-pharmaceutical dosage form.
5.5 Products containing only ingredient(s) such as roselle, jasmine, rose, chamomile,
chrysanthemum flower, ginger (rhizome), vanilla(stem), mint leaf, lemon peel and
cinnamon bark (with/without Camelia sinensis) will be regulated by FSQD.
5.6 Fruit ingredients that are not commonly consumed as food in Malaysia will be
considered as active ingredient.
Page 5 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
2 Antiaris toxicaria (Pers.) Lesch. Bark cloth tree, antiaris, false iroko, false mvule,
upas tree
7 Bile
16 Colchicum Spp. (all species) Autumn crocus, Meadow saffron, Naked lady
20 Datura Spp. (all species) Jimson weed, Devil’s apple, Green Dragon, Zombie’s
Cucumber, Moon Weed, Trumpet Lily, Stinkweed
Page 6 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
22 Dioscorea Hispida
30 Glucosamine
31 Glutathione
32 Gypsum Fibrosum
33 Hyaluronic acid
Page 7 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
45 Pearl
47 Placenta
52 Resveratrol
54 Scilla sinensis
Notes:
This list :
is a compilation by the FDI committee.
is not meant to be exhaustive and will be reviewed from time to time.
shall be read in conjunction with the current laws and regulations together with other relevant
legislations, where applicable, governing pharmaceutical and natural products for human use in
Malaysia.
Page 8 of 9
Drug Registration Guidance Document (DRGD) Third Edition, Seventh Revision January 2024
Regulated by FSQD
CLASSIFICATION OF FOOD OR DRUG PRODUCTS Regulated by NPRA
PRODUCT Classification of FDI under food or drug
DRUG FOOD